Assessing Palladyne AI (PDYN) Valuation After HANGTIME Defense Contract Win
Palladyne AI PDYN | 0.00 |
Palladyne AI (PDYN) moved back into focus after announcing the HANGTIME contract with the U.S. Air Force Research Laboratory, which uses its SwarmOS platform to coordinate autonomous systems across space, air, maritime, and land domains.
The HANGTIME announcement comes after a volatile stretch for Palladyne AI. Over the last 30 days the share price return is about 64%, and the year to date gain is 48%, while the 1 year total shareholder return is a loss of 17%. This means recent momentum contrasts with a weaker longer term record.
If this kind of defense focused AI story has your attention, it could be worth scanning aerospace and defense stocks for other names where contract wins and autonomy technology are driving interest.
With the shares up 64% in a month but still carrying a recent one year loss, plus a US$9 analyst target sitting above the US$7 price, is this contract win underappreciated or is the market already pricing in future growth?
Most Popular Narrative: 22.2% Undervalued
The most followed narrative points to a fair value of $9 for Palladyne AI, compared with the recent $7 share price, and leans heavily on defense autonomy demand.
Acceleration of autonomous and swarming requirements in defense programs, including direct Air Force and Navy development contracts and the replicator initiative, positions SwarmOS and IntelliSwarm to scale into higher value software and systems revenue, which should support faster top line growth and expanding earnings.
Want to see what is baked into that $9 view? This narrative emphasizes rapid revenue expansion, improving margins and a rich future earnings multiple. Curious which assumptions really move the fair value? Read on and test whether they line up with your own expectations.
Result: Fair Value of $9 (UNDERVALUED)
However, that upside story leans heavily on early stage defense programs and U.S. government budgets, where delays or shifting priorities could easily knock this thesis off track.
Another View: Price Tag Looks Full On P/B
The $9 fair value depends on strong growth and margin improvement, but the current P/B of 6x already sits well above both the US Machinery industry at 2.7x and peers at 4.3x. That premium suggests less room for error if the optimistic path does not fully play out.
Given that gap, are you comfortable paying a higher multiple today, or would you rather wait to see more progress on revenue scale and losses narrowing?
Build Your Own Palladyne AI Narrative
If you look at the numbers and come to a different conclusion, or prefer to test your own assumptions, you can build a custom thesis for Palladyne AI in a few minutes with Do it your way.
A great starting point for your Palladyne AI research is our analysis highlighting 1 key reward and 5 important warning signs that could impact your investment decision.
Looking for more investment ideas?
If Palladyne AI has you thinking about your next move, do not stop here; widen your watchlist with a few targeted stock ideas before the market does.
- Target potential upside in companies priced below their estimated worth by scanning these 866 undervalued stocks based on cash flows that might fit your return and risk preferences.
- Ride the momentum in machine learning and automation by checking out these 24 AI penny stocks that are closely tied to the growth of intelligent technologies.
- Tap into long term themes in digital assets through these 18 cryptocurrency and blockchain stocks and spot listed businesses closely linked to blockchain and cryptocurrency adoption.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
